Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

95 trials

NCT06820515
Recruiting
ATHNdataset Registry
Not applicable · United States · 1 site
Registry update: 21 Apr 2026
NCT06147414
Recruiting
Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Not applicable · France · 1 site
Registry update: 21 Oct 2026
NCT06379789
Recruiting
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
Phase 1/2 · Australia, Brazil, Canada, Germany, Spain, France, United Kingdom, Italy, United States · 55 sites
Registry update: 21 Oct 2026
NCT07414511
Recruiting
Hemophilia A Research Program
Not applicable · United States · 1 site
Registry update: 17 Feb 2026
NCT06461533
Recruiting
A Survey of Susoctocog Alfa (Genetical Recombination) in Participants With Acquired Haemophilia A
Not applicable · Japan · 1 site
Registry update: 7 Aug 2026
NCT07644832
Recruiting
An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII Deficiency
Phase 1/2 · China · 9 sites
Registry update: 12 Jun 2026
NCT06349473
Recruiting
A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
Phase 1 · Canada, United States · 10 sites
Registry update: 2 Jul 2026
NCT07437404
Recruiting
Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients.
Phase 3 · China · 1 site
Registry update: 27 Feb 2026
NCT06352216
Recruiting
Prevalence of Synovitis in Patients With Haemophilia A
Not applicable · Germany · 1 site
Registry update: 16 Apr 2024
NCT06145373
Recruiting
A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
Phase 4 · Spain, Italy, Taiwan, United States · 8 sites
Registry update: 23 Sept 2026
Conflicting statuses (not updated in the registry for 1 month)
NCT06003387
Recruiting
Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
Phase 3 · Australia, Bulgaria, Brazil, Canada, Hong Kong, Israel, South Korea, Mexico, Poland, Saudi Arabia, Singapore, Taiwan, United States, South Africa · 32 sites
Registry update: 27 Aug 2026
NCT06222697
Recruiting
A Study to Learn More About the Safety of Damoctocog-alfa-pegol When Used in Routine Medical Care in Korean Participants With Hemophilia A
Not applicable · South Korea · 1 site
Registry update: 22 Jun 2026
NCT06238908
Recruiting
Safety and Efficacy Study of NGGT003 in Hemophilia A Patients
Early phase 1 · China · 1 site
Registry update: 21 Feb 2025
NCT06111638
Recruiting
Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs
Phase 2/3 · China · 10 sites
Registry update: 17 Mar 2026
2022-502061-17-00
Recruiting
Nuwiq Dosing and outcomes In the ManagEment of women/girls with haemophilia A Needing FVIII treatment for Surgery – an International, Open-label, Non-controlled study (NuDIMENSION)
Phase 4 · Germany, Spain, Finland, France, Italy, Romania · 12 sites
Registry update: 10 Jul 2026
NCT05935358
Recruiting
Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
Phase 4 · Germany, Spain, Finland, France, United Kingdom, Croatia, India, Italy, North Macedonia, Serbia, United States · 18 sites
Registry update: 12 May 2026
NCT05888870
Recruiting
ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor
Phase 4 · China · 1 site
Registry update: 24 Feb 2025
NCT06090201
Recruiting
Severe Congenital Hemostatic Defects, Cerebral MIcrobleeds and COGnition
Not applicable · France · 1 site
Registry update: 22 May 2026
2022-502060-21-00
Recruiting
Nuwiq for Perioperative management Of patients With haemophilia A on Emicizumab Regular prophylaxis study (NuPOWER)
Phase 4 · Germany, Spain, Finland, France, Croatia, Italy · 11 sites
Registry update: 25 Sept 2025
NCT05987449
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
Phase 1/2 · Canada, Spain, Italy, New Zealand, Poland, United States · 14 sites
Registry update: 5 Nov 2026

Ordered by registry start date. Freshness and sponsorship never change the order.